Stockscreener 앱 받기
45.68
8.20%
3.46
시장 영업 전:
45.34
-0.34
-0.74%
Spyre Therapeutics Inc (SYRE) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
0.50%
57.17
|
56.89 | 41.94 | 53.57 | 55.39 |
| Operating Income/Loss |
0.50%
-57.17
|
-56.89 | -41.94 | -53.57 | -55.39 |
| Nonoperating Income/Loss |
111.72%
-5.358
|
45.70 | 5.218 | 8.779 | -13.62 |
| Income/Loss From Continuing Operations Before Tax |
459.15%
-62.53
|
-11.18 | -36.72 | -44.79 | -69.01 |
| Income Tax Expense/Benefit |
-
|
- | - | -0.015 | 0.018 |
| Income/Loss From Continuing Operations After Tax |
459.15%
-62.53
|
-11.18 | -36.72 | -44.77 | -69.03 |
Net Income/Loss
|
459.15%
-62.53
|
-11.18 | -36.72 | -44.77 | -69.03 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
자본화:
|
볼륨(24시간):